Relation of Red Cell Distribution Width to Glucose Metabolism and Adverse Long-Term Prognosis in Patients with Acute Coronary Syndrome
Ke Xiong,Chenbo Xu,Xiling Shou,Mengya Dong
DOI: https://doi.org/10.2147/DMSO.S395923
2023-01-11
Abstract:Ke Xiong, 1 Chenbo Xu, 2 Xiling Shou, 1 Mengya Dong 1 1 Department of Cardiovascular Medicine, Shaanxi Provincial People's Hospital, Xi'an, 710068, People's Republic of China; 2 Department of Cardiovascular Medicine, First Affiliated Hospital of Medical College, Xi'an Jiaotong University, Xi'an, 710061, People's Republic of China Correspondence: Mengya Dong, Department of Cardiovascular Medicine, Shaanxi Provincial People's Hospital, 256 West Youyi Road, Xi'an, Shaanxi, 710068, People's Republic of China, Tel +86– 15802943974, Email Introduction: Red cell distribution width (RDW) reflects the heterogeneity of red blood cell size. However, few studies examined whether RDW is related to glucose metabolism indices, such as fasting blood glucose (FBG) and hemoglobin A1c (HbA1c), diabetic mellitus (DM) state or long-term outcomes of acute coronary syndrome (ACS) patients. Methods and Results: A total of 448 consecutive patients with ACS were enrolled in this study. All patients were followed up for major cardiovascular adverse events (MACEs), and the mean follow-up was 952 days. Linear regression analysis showed that RDW inversely correlated with FBG but not HbA1c or DM. Kaplan-Meier survival curve analysis demonstrated that higher RDW levels were significantly positively associated with MACEs in the whole study population and the ACS patients with high FBG but not the low FBG group. Cox multivariate regression analysis revealed the independent function of RDW on MACEs in all ACS patients and ACS patients with high FBG. The receiver operating characteristic (ROC) curve demonstrated the optimal cutoff value of RDW for MACEs. Conclusion: We first reported that higher RDW was associated with decreased FBG but not HbA1c or DM and an increased risk of MACEs in patients with ACS. This relationship was also found in ACS patients with higher FBG levels but not in ACS patients with lower FBG. Keywords: red cell distribution width, HbA1c, fasting blood glucose, percutaneous coronary intervention, acute coronary syndromes, major adverse cardiovascular events Coronary artery disease (CAD) produces immense health and economic burdens globally. 1 Acute coronary syndrome (ACS) is an acute manifestation of CAD, and it remains a leading cause of high morbidity and mortality despite great progress in prevention and treatment. 2 Therefore, the identification of risk factors for ACS is of vital importance to improve prognosis. Diabetes mellitus (DM) is a well-established risk factor for ACS. 3,4 The prognosis of ACS is worse in patients with DM than patients without DM. 5–7 Therefore, additional attention should be given to patients with ACS and DM. Red cell distribution width (RDW) is a part of a standard complete blood count and a measure of variation in the volume of red blood cells. RDW has been almost exclusively used for the differential diagnosis of anemia. However, recent evidence identified a relationship between RDW and various disorders, including CAD and DM, due to its association with several pathophysiological processes, such as inflammation and oxidative stress. 8 Lippi et al published one of the first studies to investigate the role of RDW in ACS in 2009. They reported that the level of RDW was higher in ACS than non-ACS patients. 9 Later research demonstrated that RDW was a predictive biomarker of adverse outcomes in ACS. 10–12 Several studies reported the relationship between RDW and hemoglobin A1c (HbA1c) and prognosis in DM. 13–16 However, few reports investigated the relationship between RDW, fasting blood glucose (FBG), and major adverse cardiovascular events (MACEs) in the ACS population after percutaneous coronary intervention (PCI). The present study determined the relationship between baseline RDW levels and FBG and examined the prognostic role of RDW in ACS patients with different FBG levels. This study was a single-center, prospective, and observational cohort study. From January 2013 to February 2014, a total of 448 consecutive patients with ACS after PCI participated in this study at the Cardiology Department of Shaanxi Provincial People's Hospital. ACS was defined as unstable angina (UA), non-ST-segment elevation myocardial infarction (NSTEMI), and ST-segment elevation myocardial infarction (STEMI), which were diagnosed according to the criteria of the American College of Cardiology/American Heart Association. 17,18 Patients who suffered from active infection, hematological proliferative diseases, active or chronic inflammatory or autoimmune diseases, liver or renal dysfunction, malignancies, pregnancy, or unavailable complete blood count or medical records were excluded from the study. The st -Abstract Truncated-
endocrinology & metabolism